Catalyst Wire Dossier Catalyst Wire Dossier

Linagliptin

linagliptin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

70 regulatory and trial events tracked for Linagliptin, covering 2011-06-07 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination [Phase 4]

See pricing